Regional survey of tuberculosis risk assessment in rheumatology outpatients commencing anti-TNF-α treatment in relation to British Thoracic Society guidelines

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 9, Issue 3, 2009, Pages 225-230

  John, H ^a   Buckley, C ^b   Koh, L ^a   Obrenovic, K ^a   Erb, N ^a   Rowe, Ian F ^b  

^a DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

^b WORCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Anti TNF ; Guidelines; Regional survey; Risk assessment; Therapy; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ANTIRHEUMATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANAMNESIS; ARTICLE; BIRTHPLACE; CHEMOPROPHYLAXIS; CLINICAL EXAMINATION; CLINICAL PRACTICE; ETHNICITY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; OUTPATIENT; PATIENT COMPLIANCE; PATIENT REFERRAL; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; RISK ASSESSMENT; RISK FACTOR; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; OPPORTUNISTIC INFECTION; OUTPATIENT DEPARTMENT; PRACTICE GUIDELINE; RHEUMATOID ARTHRITIS; STATISTICS; UNITED KINGDOM;

AMBULATORY CARE FACILITIES; ANTIRHEUMATIC AGENTS; ANTITUBERCULAR AGENTS; ARTHRITIS, RHEUMATOID; CHEMOPREVENTION; ENGLAND; HUMANS; OPPORTUNISTIC INFECTIONS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 69049094127     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.9-3-225     Document Type: Article

References (18)

1. Emery P. Treatment of rheumatoid arthritis. BMJ 2006;332:152-5.
2. Department of Health. Stopping tuberculosis in England: An action plan from the Chief Medical Officer. London: DH, 2004.
3. Silman A, Symmons D, Scott D, Griffiths ID. British Society for Rheumatology Biologics Register. Ann Rheum Dis 2003;62(Suppl 2):iI28-9.
4. Dixon WG, Watson K, Lunt M et al. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy. Arthritis Rheum 2006;54:2368-76.
5. Ledingham J, Deighton C on behalf of the British Society for Rheumatology Standards GaAWG. Update on the British Society for Rheumatology guidelines for prescribing TNFa blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology 2005;44:157-63.
6. British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobactcerium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax 2005;60:800-5.
7. Ledingham J,Wilkinson C, Deighton C. British Thoracic Society (BTS) recommendations for assessing risk and managing tuberculosis in patients due to start anti-TNF-alpha treatments. Rheumatology 2005;44:1205-6.
8. Erb N, Duncan RC, Raza K et al. A regional audit of the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases in the West Midlands. Rheumatology (Oxford) 2002;41:1021-4.
9. Paskins Z, Potter T, Erb N, Obrenovic K, Rowe IF. Audits of the prevention and treatment of corticosteroid-induced osteoporosis in out-patients with rheumatic diseases in the West Midlands. Clin Med 2006;6:183-7.
10. Price-Forbes AN, Callaghan R, Allen ME, Rowe IF. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines. Rheumatology (Oxford) 2005;44: 921-4.
11. Sandhu RS, Treharne GJ, Justice EA et al. Accessibility and quality of secondary care rheumatology services for people with inflammatory arthritis: A regional survey. Clin Med 2007;7:579-84.
12. Kay LJ, Griffiths ID for the BSR Biologics Register Management committee. UK consultant rheumatologists' access to biological agents and views on the BSR Biologics Register. Rheumatology 2006;45:1376-9.
13. Office of National Statistics. Census 2001-West Midlands and its people. www statistics gov uk/census2001/profiles/commentaries/ west_midlandsasp#Ethnicity2001
14. Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998;53:536-45.
15. Keane J. TNF-blocking agents and tuberculosis: New drugs illuminate an old topic. Rheumatology 2005;44:714-20.
16. Nizam S, Emery P. Attenuated response to purified protein derivative in patients with rheumatoid arthritis. Ann Rheum Dis 2006;65:980
17. Lalvani A. Diagnosing tuberculosis infection in the 21st century: New tools to tackle an old enemy. Chest 2007;131:1898-906.
18. Pouchot J, Grasland A, Collet C et al. Reliability of tuberculin skin test measurement. Ann Intern Med 1997;126:210-4.